ES8602415A1 - Procedimiento de preparacion del principio activo de un medicamento inmunomodulador a base de lijados de los generos de bacterias. - Google Patents

Procedimiento de preparacion del principio activo de un medicamento inmunomodulador a base de lijados de los generos de bacterias.

Info

Publication number
ES8602415A1
ES8602415A1 ES535213A ES535213A ES8602415A1 ES 8602415 A1 ES8602415 A1 ES 8602415A1 ES 535213 A ES535213 A ES 535213A ES 535213 A ES535213 A ES 535213A ES 8602415 A1 ES8602415 A1 ES 8602415A1
Authority
ES
Spain
Prior art keywords
immunomodulating
biological origin
medicine
preparing
bacteria
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES535213A
Other languages
English (en)
Other versions
ES535213A0 (es
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck Sante SAS
Original Assignee
LIPHA SAS
LIPHA Liyonnaise Industrielle Pharmaceutique
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by LIPHA SAS, LIPHA Liyonnaise Industrielle Pharmaceutique filed Critical LIPHA SAS
Publication of ES8602415A1 publication Critical patent/ES8602415A1/es
Publication of ES535213A0 publication Critical patent/ES535213A0/es
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66Microorganisms or materials therefrom
    • A61K35/74Bacteria
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/04Immunostimulants
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Mycology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

PROCEDIMIENTO DE PREPARACION DEL PRINCIPIO ACTIVO DE UN MEDICAMENTO INMUNOMODULADOR A BASE DE LISADOS DE DOS GENEROS DE BACTERIAS. COMPRENDE: A) PROCEDER A UNA PRIMERA SIEMBRA DE UN MEDIO DE CULTIVO APROPIADO CON UN INOCULO DE BACTERIAS DEL GENERO KLEBSIELLA; B) INFECTAR, EN EL CURSO DE LA FASE DE CRECIMIENTO, LAS BACTERIAS POR INTRODUCCION DE SUS FAGOS HOMOLOGOS; C) VIGILAR LA EVOLUCION DE LA LISIS HASTA UNA ETAPA FIJADA; D) PROCEDER LUEGO A UNA SEGUNDA SIEMBRA DEL MEDIO DE CULTIVO CON UN INOCULO DE BACTERIAS DEL GENERO ESCHERICHIA; E) INFECTAR EN EL CURSO DE LA FASE DE CRECIMIENTO DE LAS BACTERIAS DEL SEGUNDO GENERO POR INTRODUCCION DE SUS FAGOS HOMOLOGOS; F) VIGILAR LA EVOLUCION DE LA LISIS DE ESTAS BACTERIAS DEL SEGUNDO GENERO HASTA UNA ETAPA FIJADA; G) ELIMINAR FINALMENTE LAS BACTERIAS NO DESINTEGRADAS POR LISIS; Y H) RECOGER EL FILTRADO DE LISIS OBTENIDO A PARTIR DE LAS DOS BACTERIAS.
ES535213A 1983-08-17 1984-08-16 Procedimiento de preparacion del principio activo de un medicamento inmunomodulador a base de lijados de los generos de bacterias. Granted ES535213A0 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR8313362A FR2550707B1 (fr) 1983-08-17 1983-08-17 Medicament immunomodulateur d'origine biologique et son procede de preparation

Publications (2)

Publication Number Publication Date
ES8602415A1 true ES8602415A1 (es) 1985-12-01
ES535213A0 ES535213A0 (es) 1985-12-01

Family

ID=9291646

Family Applications (1)

Application Number Title Priority Date Filing Date
ES535213A Granted ES535213A0 (es) 1983-08-17 1984-08-16 Procedimiento de preparacion del principio activo de un medicamento inmunomodulador a base de lijados de los generos de bacterias.

Country Status (22)

Country Link
EP (1) EP0139551B1 (es)
JP (1) JPS6069022A (es)
AT (1) ATE36240T1 (es)
AU (1) AU564652B2 (es)
CA (1) CA1229566A (es)
CS (1) CS270410B2 (es)
DD (1) DD232432A5 (es)
DE (1) DE3473228D1 (es)
DK (1) DK160807C (es)
ES (1) ES535213A0 (es)
FR (1) FR2550707B1 (es)
HU (1) HU193217B (es)
IL (1) IL72589A (es)
IN (1) IN161616B (es)
MA (1) MA20203A1 (es)
NO (1) NO843274L (es)
NZ (1) NZ209171A (es)
OA (1) OA07794A (es)
PT (1) PT79090B (es)
SU (1) SU1487815A3 (es)
YU (1) YU143284A (es)
ZA (1) ZA846151B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4876194A (en) * 1986-07-22 1989-10-24 Hightech Receptor Ab Protein L and subfragments thereof, with immunoglobulin binding activity, a process for preparing thereof, reagent kit, pharmaceutical composition and a peptococcus magnus strain
FR2620130B1 (fr) * 1987-09-08 1990-01-12 Lipha Nouveaux polysaccharides hydrosolubles, leur procede d'obtention, leur application a titre de medicaments et preparation les renfermant
IL88480A0 (en) * 1987-11-27 1989-06-30 Univ Toronto Proteinaceous compositions
AU6838996A (en) * 1996-05-27 1998-01-05 Alexei Nikolaevich Parfenov Use of streptococcus faecium strains and composition containing the same
EP1487273B1 (en) 2002-02-13 2009-01-21 Immunology Laboratories, Inc. Compositions and methods for treatment of microbial infections

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE758977A (fr) * 1969-11-17 1971-05-17 Glaxo Lab Ltd Procede biochimique
CH633188A5 (fr) * 1978-05-26 1982-11-30 Om Laboratoires Sa Medicament contre des maladies infectieuses des voies respiratoires.
CH639852A5 (fr) * 1979-07-26 1983-12-15 Om Laboratoires Sa Medicament contre les maladies infectieuses des voies urinaires et digestives.
US4322405A (en) * 1981-04-06 1982-03-30 Laboratoires Om Societe Anonyme Method for treating rheumatoid arthritis

Also Published As

Publication number Publication date
HUT35013A (en) 1985-05-28
IL72589A0 (en) 1984-11-30
IL72589A (en) 1988-01-31
SU1487815A3 (ru) 1989-06-15
EP0139551A2 (fr) 1985-05-02
ZA846151B (en) 1985-03-27
CS592184A2 (en) 1989-11-14
PT79090A (fr) 1984-09-01
DD232432A5 (de) 1986-01-29
MA20203A1 (fr) 1985-04-01
FR2550707B1 (fr) 1986-02-28
NZ209171A (en) 1988-10-28
ES535213A0 (es) 1985-12-01
OA07794A (fr) 1986-11-20
AU3193884A (en) 1985-02-21
DK160807B (da) 1991-04-22
JPS6069022A (ja) 1985-04-19
PT79090B (fr) 1986-08-14
EP0139551B1 (fr) 1988-08-10
NO843274L (no) 1985-02-18
YU143284A (en) 1991-02-28
EP0139551A3 (en) 1985-07-10
DE3473228D1 (en) 1988-09-15
DK393884D0 (da) 1984-08-16
DK393884A (da) 1985-02-18
CA1229566A (fr) 1987-11-24
CS270410B2 (en) 1990-06-13
HU193217B (en) 1987-08-28
DK160807C (da) 1991-10-07
AU564652B2 (en) 1987-08-20
FR2550707A1 (fr) 1985-02-22
IN161616B (es) 1988-01-02
ATE36240T1 (de) 1988-08-15

Similar Documents

Publication Publication Date Title
IT8520672A0 (it) Contenitore composito per prodotti solidi sterili.
EP0225608A3 (de) Arzneimittel
GB2231335A (en) Strain of bacteria escherichia coli, producer of l-threonine
CA2115348A1 (en) Process for the production of pharmaceutical preparations containing human protein for infusion or injection purposes
HU9201937D0 (en) Aryl ethers, process for their production, and for the production of medical preparations containing them as active agents
EP0427588A3 (en) System for the administration of sterile liquids, especially pharmaceutical, nutritive or energetic
HU913776D0 (en) Process for the production of heparosane-n,o-sulphates, and medical preparations containing them as active agents
NZ220265A (en) Sterilised, concentrated milk product and production thereof
HU890442D0 (en) Process for the production of new carbinole derivatives and medical preparations containing them, and agrochemical preparations containing such carbinole derivatives
ES8602415A1 (es) Procedimiento de preparacion del principio activo de un medicamento inmunomodulador a base de lijados de los generos de bacterias.
IT1148158B (it) Impiego di lisati batterici derivati da ceppi di escherichhia coli, per il trattamento di artrite reumatoide
HU9201358D0 (en) 2-amino-pirimidine-4-carboxamide derivatives, process for their production and for the production of medical preparations containing them as active agents
IT8522711A0 (it) Metodo di disinfestazione diprodotti alimentari ed impianto per l'attuazione del metodo.
ES8707955A1 (es) Un procedimiento para la preparacion pirazolidinonas biciclicas'
EG18213A (en) Pharmaceutical formulation for the treatment of bacterial infections
GR862698B (en) Cephalosporin derivatives and method for preparing them
FR2581507B1 (fr) Procede et produits pour la lutte contre le pyrale de la vigne, sparganothis pilleriana
IT8720920A0 (it) Banco per l'esposizione e la conservazione di prodotti alimentari, in particolare diprodotti alimentari o di altri prodotti chimici e farmaceutici deperibili, provvisto di ripiani amovibili.
MN426A8 (en) Preparation of lactic-acidic product vitaminized by b12 using propion-acidic p.shermani bacteria
HU905975D0 (en) Process envolving vacuum-technics for the production of microbiologically sterile fruit preparations while keeping their biological value and fulfilling special requirements
IT1202285B (it) Procedimento per la cottura di prodotti alimentari quali prosciutti e simili,stampo per l'attuazione del procedimento e prodotti cosi' ottenuti
HU9200315D0 (en) Process for the isolation of nautural lyzozyme (ec 3.2.1.17) and its use as human or veterinary medical product, or conservation product of meat and meat products
AR243128A1 (es) Envase-servidor de productos liquidos y otros usos, de tipo descartable
GB8728724D0 (en) Sterile product
IT8402909A0 (it) Procedimento per la preparazione del prodotto farmaceutico o-acetil-1-carnitina cloruro.

Legal Events

Date Code Title Description
FD1A Patent lapsed

Effective date: 19960603